找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Complications in Uveitis; Francesco Pichi,Piergiorgio Neri Book 2020 Springer Nature Switzerland AG 2020 Uveitic cataract.Uveitic glaucoma

[復制鏈接]
樓主: Addendum
21#
發(fā)表于 2025-3-25 03:21:00 | 只看該作者
Kelly A. Davis,Krzysztof Matyjaszewskie achievement of high-resolution images, useful in distinguishing subtle changes in the anatomy and pathology of structures like the retroiridal face, CB, and pars plana (PP), which are not precisely accessible by routine USG. This technology has a tissue depth penetration of approximately 3–6 mm an
22#
發(fā)表于 2025-3-25 07:44:02 | 只看該作者
23#
發(fā)表于 2025-3-25 15:34:50 | 只看該作者
24#
發(fā)表于 2025-3-25 17:28:25 | 只看該作者
Ciliary Processes Complications from Uveitise achievement of high-resolution images, useful in distinguishing subtle changes in the anatomy and pathology of structures like the retroiridal face, CB, and pars plana (PP), which are not precisely accessible by routine USG. This technology has a tissue depth penetration of approximately 3–6 mm an
25#
發(fā)表于 2025-3-25 22:19:06 | 只看該作者
26#
發(fā)表于 2025-3-26 03:40:40 | 只看該作者
Treatment of Inflammatory Choroidal Neovascular Membranestion control. The association of steroids with immunosuppressive agents is most appropriate therapy for inflammatory CNV. Anti-VEGF agents are commonly associated with systemic therapy..Although there is no comparative study between immunosuppressive agents, mycophenolate mofetil seems to offer a pr
27#
發(fā)表于 2025-3-26 06:44:33 | 只看該作者
bemanagement of the complication. This multi-disciplinary approach to complications of uveitis will provide to the readers the tools to prevent them, or to correctly manage the. It will be a book mainly directe978-3-030-28394-0978-3-030-28392-6
28#
發(fā)表于 2025-3-26 09:54:52 | 只看該作者
Limbal Stem Cell Deficiency in Inflammatory Disordersration onto the cornea (conjunctivalization) with severe visual impairment. Lamellar and/or penetrating keratoplasty cannot be successful as donor corneal epithelium is replaced by that of the recipient within months. In the presence of LSCD graft re-epithelialisation will not take place, with subse
29#
發(fā)表于 2025-3-26 16:06:37 | 只看該作者
30#
發(fā)表于 2025-3-26 19:52:28 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 17:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
普格县| 天祝| 于田县| 阿拉善左旗| 澜沧| 涟水县| 灵台县| 巴中市| 扶风县| 灵宝市| 逊克县| 陆良县| 诏安县| 伊宁市| 平潭县| 梧州市| 湾仔区| 大安市| 电白县| 宜兰县| 乳源| 闽侯县| 从化市| 会宁县| 郯城县| 饶阳县| 枞阳县| 壤塘县| 巴马| 永昌县| 韩城市| 迭部县| 酒泉市| 洪雅县| 麻江县| 梁河县| 正镶白旗| 百色市| 尖扎县| 廉江市| 纳雍县|